Company
BriaCell Therapeutics Corp. (BCTX)
Standardized SEC financial data for BriaCell Therapeutics Corp. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001610820 · NASDAQ · Pharmaceutical Preparations.
Return on equity
-151.8%
Free cash flow
-$28.6M
Current ratio
5.01×
EPS (diluted)
$-62.19
Income statement
| USD | FY2021 | FY2022 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| R&D expense | $2.0M | — | $8.0M | $15.3M | $27.2M | $21.3M |
| SG&A expense |
Balance sheet
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $57.3M | $41.0M | $21.3M | $862K | — | $10.5M |
| Total current assets |
Cash flow
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Operating cash flow | -$7.8M | -$12.5M | -$23.7M | -$24.1M | -$28.2M |
| Capital expenditures | — | — |
Get BCTX data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/BCTX/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/BCTX/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"